New point-of-care UTI technology to address antibiotic resistance

TTP, an independent technology and product development company, has partnered with ODx Innovations, a company committed to developing a system for assessing urinary tract infections (UTIs). The ODx system offers the potential to revolutionise the turnaround time for the assessment of suspected UTIs, reduce the use of antibiotics and provider faster access to optimal antimicrobial therapy.

Malaria mosquito research: insect control update

Scientists have discovered a malaria transmission-blocking microbe, which represents an important stride in the fight against the disease, reported in a study funded by Wellcome Trust and the UK GCRF Network ANTI-VeC.

Squalene-based nanoparticles in the treatment of septic shock and uncontrolled inflammation

Researchers from the Galien Institute at Paris-Saclay University/CNRS have developed nanoparticles that are effective in the treatment of severe inflammatory processes, which can be found in many pathologies, such as COVID-19. This research was published recently in the journal Science Advances.

Collaboration on automated digital cell morphology solution enhances workflows

HORIBA UK, Medical has introduced a new automated digital cell morphology solution in collaboration with CellaVision to help haematology laboratories simplify and expedite the performance of blood and body fluid differentials. CellaVision’s digital cell morphology systems can now be integrated with HORIBA’s HELO automated haematology platform, enabling two-way data flow and rapid validation of cell morphology results. These combined systems automate a number of steps that would otherwise be undertaken manually, significantly enhancing laboratory workflows and increasing productivity.

Pathologists and healthcare leaders urged to collaborate to transform cancer diagnostics

Leica Biosystems has launched The Future of Pathology Expert Report, which calls for pathologists and healthcare leaders to collaborate in pursuit of their common goal – to improve cancer diagnostics. Given the uncertain times currently faced by healthcare communities globally, The Future of Pathology Report details how the field of pathology can evolve to meet these challenges.

Breaking optical barriers to deliver outstanding image quality

Olympus has received a Gold Edison Award for its X Line objectives in the Applied Technology category and Optical & Imaging Technologies subcategory. The Edison Award is one of the most prestigious accolades honouring excellence in new product development, design and innovation.

Next-generation microscopy image analysis with deep-learning technology

Using the power of deep learning, Olympus cellSens imaging software for microscopy offers significantly improved segmentation analysis, such as label-free nucleus detection and cell counting, for more accurate data and efficient experiments.

Assisting leukaemia research at the UCL Cancer Institute

Researchers at the Cancer Institute, University College London (UCL), are using INTEGRA’s electronic pipette range to simplify workflows. Yvette Hoade (pictured), a research technician in the Payne Laboratory, Department of Haematology, is investigating mutations associated with various blood diseases such as bone marrow failure and myelodysplastic syndrome (MDS), both of which are age-related disorders that greatly increase the risk of developing leukaemia.

New App Launched: Pathology in Practice in action and on the move

Under the current lockdown conditions, keeping up to date with the very latest news, innovative technology and products in the biomedical science industry is easy. Pathology in Practice is now available via Apps free both in the Google Play Store and the Apple App Store. The App provides access to the current and previous digital issues of Pathology in Practice, together with copies of The Clinical Services Journal. Click on this news item to access the respective links.

Translocation and partial tandem duplication detection with updates to SureSeq NGS portfolio

Oxford Gene Technology (OGT), a Sysmex Group company, has announced the addition of accurate detection capabilities for translocations and difficult-to-sequence partial tandem duplications (PTDs) in its popular myPanel customisable SureSeq NGS panels. This latest update is, for example, beneficial to researchers investigating myeloid disorders like chronic myeloid leukaemia (CML), myeloproliferative neoplasms (MPNs) and acute myeloid leukaemia (AML), now enabled with BCR-ABL fusion gene and KMT2A-PTD detection.

Win an INTEGRA electronic micropipette and never look back

INTEGRA Biosciences is offering laboratories a chance to win a VIAFLO multichannel electronic pipette of their choice. The VIAFLO electronic pipette is designed to offer better pipetting for virtually any application, helping users to achieve excellent results faster.

From Grams to Genes: conventional microbiology in the molecular age

Molecular methods have become widely available for diagnostic microbiology but certain questions arise when considering their introduction. For example, can they replace conventional methods relia-bly, is training to use such complex assays available, and are the improvements in turnaround time and improved sensitivity actually worth the cost? Mike Wren considers some of these issues.

Support provided by digital pathology workflow software

Inspirata is making available its digital pathology workflow software, on a free-of-charge basis, to assist NHS trusts and pathology networks in maintaining histopathology reporting throughput, as they wrestle with current and/or projected limitations in the availability of human resources caused by the coronavirus pandemic.

Leading microscopy and inspection solutions at world’s first virtual analytical summit

Olympus will exhibit its leading microscopy and industrial inspection solutions to a global online audience at the new SelectScience Virtual Analytical Summit 2020, taking place from 31 March to 2 April 2020. The event is free to register and attend and will connect over 900,000 scientists with presentations, workshops, video interviews, virtual booths, cutting-edge resources, the latest product and application news, Q&As, networking and live-chat opportunities.

Returnees to the HCPC register respond to coronavirus demand

Many allied health professionals (AHPs) who have recently left the Health and Care Professions Council (HCPC) register have expressed a willingness to return and help during the current coronavirus national emergency. For this reason, the HCPC has agreed to automatically re-register all AHPs who have voluntarily left the HCPC register over the past three years onto a temporary COVID-19 Register.

Haemostasis instrument validated for use with UK NEQAS BC samples

A study has shown that UK National External Quality Assessment Scheme for Blood Coagulation (UK NEQAS BC) lyophilised plasma samples can be tested on HORIBA UK, Medical’s Yumizen G200 haemostasis instrument, confirming that it is accurate and suitable for use in external quality assessment (EQA) exercises.

All-Party Parliamentary Group for Life Sciences relaunched

The All-Party Parliamentary Group (APPG) for Life Sciences was relaunched recently. Chaired by Daniel Zeichner MP, the APPG will raise awareness of UK life sciences among parliamentarians, and explore the challenges and opportunities facing the sector.

Celebrating National Collection of Type Cultures’ centenary

Public Health England is the custodian of four unique collections of expertly preserved, authenticated bacteria, viruses, fungi and cell lines of known provenance for use in medical science and laboratory healthcare.

Fast detection of low-abundance proteins using far-red HI-LED lighting

Syngene has introduced a far-red HI-LED lighting option for its new design of G:BOX Chemi and G:BOX mini multi-application gel and blot imaging systems. This quick-fit, environmentally friendly lighting enables fast workflow and precise detection of IR fluorescently labelled proteins on gels and blots.

Natural killer cells and relapsed/refractory acute myeloid leukaemia

Biopharmaceutical company Kiadis and The Ohio State University (OSU) – Arthur G James Cancer Hospital and Richard J Solove Research Institute have launched a first-in-human clinical trial in patients with relapsed/refractory acute myeloid leukaemia (R/R AML) with off-the-shelf natural killer (NK) cells manufactured using Kiadis’ FC21 mbIL21 feeder cells and proprietary universal donor platform. The trial is expected to provide further clinical proof-of-concept of Kiadis’ K-NK003 product.